Compare Jubilant Pharmova with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA DIVIS LABORATORIES JUBILANT PHARMOVA /
DIVIS LABORATORIES
 
P/E (TTM) x 14.0 67.0 20.8% View Chart
P/BV x 1.9 18.2 10.6% View Chart
Dividend Yield % 0.7 0.3 230.3%  

Financials

 JUBILANT PHARMOVA    DIVIS LABORATORIES
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-20
DIVIS LABORATORIES
Mar-20
JUBILANT PHARMOVA /
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs7272,258 32.2%   
Low Rs2301,467 15.7%   
Sales per share (Unadj.) Rs574.7203.2 282.8%  
Earnings per share (Unadj.) Rs56.451.9 108.8%  
Cash flow per share (Unadj.) Rs85.458.9 145.1%  
Dividends per share (Unadj.) Rs5.0016.00 31.3%  
Dividend yield (eoy) %1.00.9 121.6%  
Book value per share (Unadj.) Rs351.8275.4 127.8%  
Shares outstanding (eoy) m159.28265.47 60.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.89.2 9.1%   
Avg P/E ratio x8.535.9 23.6%  
P/CF ratio (eoy) x5.631.6 17.7%  
Price / Book Value ratio x1.46.8 20.1%  
Dividend payout %8.930.9 28.7%   
Avg Mkt Cap Rs m76,220494,429 15.4%   
No. of employees `000NANA-   
Total wages/salary Rs m21,2776,211 342.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m91,54453,944 169.7%  
Other income Rs m4741,896 25.0%   
Total revenues Rs m92,01855,841 164.8%   
Gross profit Rs m19,12418,232 104.9%  
Depreciation Rs m4,6191,862 248.0%   
Interest Rs m2,87471 4,025.3%   
Profit before tax Rs m12,10518,195 66.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,1234,429 70.5%   
Profit after tax Rs m8,98213,765 65.3%  
Gross profit margin %20.933.8 61.8%  
Effective tax rate %25.824.3 106.0%   
Net profit margin %9.825.5 38.5%  
BALANCE SHEET DATA
Current assets Rs m50,38355,735 90.4%   
Current liabilities Rs m26,19018,205 143.9%   
Net working cap to sales %26.469.6 38.0%  
Current ratio x1.93.1 62.8%  
Inventory Days Days776 8.6%  
Debtors Days Days5296 53.9%  
Net fixed assets Rs m72,72138,515 188.8%   
Share capital Rs m159531 30.0%   
"Free" reserves Rs m55,88072,568 77.0%   
Net worth Rs m56,03973,099 76.7%   
Long term debt Rs m37,3970-   
Total assets Rs m123,10494,250 130.6%  
Interest coverage x5.2255.8 2.0%   
Debt to equity ratio x0.70-  
Sales to assets ratio x0.70.6 129.9%   
Return on assets %9.614.7 65.6%  
Return on equity %16.018.8 85.1%  
Return on capital %16.025.0 64.2%  
Exports to sales %00-   
Imports to sales %14.821.5 68.7%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m13,51511,597 116.5%   
Fx inflow Rs m15,51544,832 34.6%   
Fx outflow Rs m13,51511,837 114.2%   
Net fx Rs m2,00032,996 6.1%   
CASH FLOW
From Operations Rs m15,42912,159 126.9%  
From Investments Rs m-3,270-835 391.8%  
From Financial Activity Rs m-10,504-10,914 96.2%  
Net Cashflow Rs m2,254411 549.1%  

Share Holding

Indian Promoters % 46.5 52.0 89.5%  
Foreign collaborators % 4.2 0.0 -  
Indian inst/Mut Fund % 26.6 37.2 71.5%  
FIIs % 24.8 20.6 120.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 48.1 102.6%  
Shareholders   87,493 193,883 45.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   IND. SWIFT  GUJ.THEMIS.  BAJAJ HEALTHCARE  LAURUS LABS   GANGA PHARMACEUTICALS  



Today's Market

5 Reasons Why Sensex Ended 873 Points Higher Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

TORRENT PHARMA at All Time High; BSE HEALTHCARE Index Up 0.7% (Market Updates)

Aug 3, 2021 | Updated on Aug 3, 2021

TORRENT PHARMA share price has hit an all time high at Rs 3,124 (up 0.9%). The BSE HEALTHCARE Index is up by 0.7%. Among the top gainers in the BSE HEALTHCARE Index today are TORRENT PHARMA (up 0.9%) and SANOFI INDIA (up 2.1%). The top losers include CIPLA and DR. REDDYS LAB .

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Make Startup Profits from Bluechip Stocks(Profit Hunter)

Jul 21, 2021

A 166-bagger stock can deliver even more gains in this decade.

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices(Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Aug 3, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 8-QTR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS